$GENZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENZYME CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENZYME CORP. Get notifications about new insider transactions in GENZYME CORP for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 10 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2010 | GENZ | GENZYME CORP | Canute Scott A | Executive VP | Option Exercise | A | 57.22 | 50,000 | 2,861,000 | 50,000 | |
Mar 17 2010 | GENZ | GENZYME CORP | Canute Scott A | Executive VP | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Mar 08 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | M | 26.50 | 16,149 | 427,949 | 0 | |
Mar 08 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | S | 56.63 | 16,149 | 914,497 | 31,058 | 47.2 K to 31.1 K (-34.21 %) |
Mar 08 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Buy | M | 26.50 | 16,149 | 427,949 | 47,207 | 31.1 K to 47.2 K (+52.00 %) |
Feb 24 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | M | 26.50 | 100,000 | 2,650,000 | 100,000 | |
Feb 24 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | S | 55.78 | 100,000 | 5,578,000 | 624,630 | 724.6 K to 624.6 K (-13.80 %) |
Feb 24 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Buy | M | 26.50 | 100,000 | 2,650,000 | 724,630 | 624.6 K to 724.6 K (+16.01 %) |
Jan 05 2010 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 455 | 0 | 455 | |
Jan 05 2010 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 610 | 0 | 610 | |
Dec 10 2009 | GENZ | GENZYME CORP | BERTOLINI ROBERT J | Director | Option Exercise | A | 49.42 | 7,125 | 352,118 | 7,125 | |
Dec 10 2009 | GENZ | GENZYME CORP | BERTOLINI ROBERT J | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Nov 25 2009 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | M | 26.50 | 200,000 | 5,300,000 | 200,000 | |
Nov 25 2009 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | S | 50.47 | 200,000 | 10,094,000 | 624,630 | 824.6 K to 624.6 K (-24.25 %) |
Nov 25 2009 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Buy | M | 26.50 | 200,000 | 5,300,000 | 824,630 | 624.6 K to 824.6 K (+32.02 %) |
Nov 10 2009 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | M | 32.52 | 3,075 | 99,999 | 0 | |
Nov 10 2009 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | M | 32.52 | 33,800 | 1,099,176 | 0 | |
Nov 10 2009 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Sell | S | 52.07 | 36,875 | 1,920,081 | 2,351 | 39.2 K to 2.4 K (-94.01 %) |
Nov 10 2009 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Buy | M | 32.52 | 36,875 | 1,199,175 | 39,226 | 2.4 K to 39.2 K (+1,568.48 %) |
Nov 05 2009 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Sell | S | 50.34 | 1,000 | 50,340 | 7,164 | 8.2 K to 7.2 K (-12.25 %) |
Oct 02 2009 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 407 | 0 | 407 | |
Oct 02 2009 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 287 | 0 | 287 | |
Sep 14 2009 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Buy | P | 55.00 | 1,000 | 55,000 | 2,550 | 1.6 K to 2.6 K (+64.52 %) |
Jul 01 2009 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 430 | 0 | 430 | |
Jul 01 2009 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 263 | 0 | 263 | |
Jun 03 2009 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | S | 61.40 | 1,809 | 111,065 | 30,783 | 32.6 K to 30.8 K (-5.55 %) |
Jun 03 2009 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Sell | S | 59.40 | 2,500 | 148,509 | 8,164 | 10.7 K to 8.2 K (-23.44 %) |
May 27 2009 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | M | 0.00 | 22,333 | 0 | 44,667 | |
May 27 2009 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | S | 56.54 | 9,637 | 544,849 | 624,630 | 634.3 K to 624.6 K (-1.52 %) |
May 27 2009 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Buy | M | 0.00 | 22,333 | 0 | 634,267 | 611.9 K to 634.3 K (+3.65 %) |
May 27 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Sell | S | 58.70 | 1,000 | 58,701 | 29,525 | 30.5 K to 29.5 K (-3.28 %) |
May 27 2009 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
May 27 2009 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | S | 56.54 | 1,641 | 92,786 | 9,335 | 11 K to 9.3 K (-14.95 %) |
May 27 2009 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Buy | M | 0.00 | 5,000 | 0 | 10,976 | 6 K to 11 K (+83.67 %) |
May 27 2009 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | M | 0.00 | 2,694 | 0 | 5,389 | |
May 27 2009 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | S | 56.54 | 885 | 50,036 | 32,592 | 33.5 K to 32.6 K (-2.64 %) |
May 27 2009 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Buy | M | 0.00 | 2,694 | 0 | 33,477 | 30.8 K to 33.5 K (+8.75 %) |
May 27 2009 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | M | 0.00 | 1,944 | 0 | 3,889 | |
May 27 2009 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Sell | S | 56.54 | 638 | 36,069 | 5,615 | 6.3 K to 5.6 K (-10.20 %) |
May 27 2009 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Buy | M | 0.00 | 1,944 | 0 | 6,253 | 4.3 K to 6.3 K (+45.11 %) |
May 27 2009 | GENZ | GENZYME CORP | COLLIER EARL M JR | Executive Vice Pres ... | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
May 27 2009 | GENZ | GENZYME CORP | COLLIER EARL M JR | Executive Vice Pres ... | Sell | S | 56.54 | 1,641 | 92,780 | 5,512 | 7.2 K to 5.5 K (-22.94 %) |
May 27 2009 | GENZ | GENZYME CORP | COLLIER EARL M JR | Executive Vice Pres ... | Buy | M | 0.00 | 5,000 | 0 | 7,153 | 2.2 K to 7.2 K (+232.23 %) |
May 26 2009 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Option Exercise | A | 58.66 | 42,750 | 2,507,715 | 42,750 | |
May 26 2009 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Option Exercise | A | 0.00 | 14,250 | 0 | 14,250 | |
May 26 2009 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | A | 58.66 | 23,038 | 1,351,409 | 23,038 | |
May 26 2009 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | A | 0.00 | 7,679 | 0 | 7,679 | |
May 26 2009 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Therapeutics ... | Option Exercise | A | 58.66 | 42,750 | 2,507,715 | 42,750 | |
May 26 2009 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Therapeutics ... | Option Exercise | A | 0.00 | 14,250 | 0 | 14,250 | |
May 26 2009 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | A | 58.66 | 14,250 | 835,905 | 14,250 | |
May 26 2009 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | A | 0.00 | 4,750 | 0 | 4,750 | |
May 26 2009 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 26 2009 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Option Exercise | A | 58.66 | 7,500 | 439,950 | 7,500 | |
May 26 2009 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 26 2009 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Buy | M | 0.00 | 2,500 | 0 | 10,664 | 8.2 K to 10.7 K (+30.62 %) |
May 26 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 26 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | A | 58.66 | 7,500 | 439,950 | 7,500 | |
May 26 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 26 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Buy | M | 0.00 | 2,500 | 0 | 30,525 | 28 K to 30.5 K (+8.92 %) |
May 26 2009 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 26 2009 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 58.66 | 7,500 | 439,950 | 7,500 | |
May 26 2009 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 26 2009 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Buy | M | 0.00 | 2,500 | 0 | 68,658 | 66.2 K to 68.7 K (+3.78 %) |
May 26 2009 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | A | 58.66 | 16,625 | 975,223 | 16,625 | |
May 26 2009 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | A | 0.00 | 5,542 | 0 | 5,542 | |
May 26 2009 | GENZ | GENZYME CORP | Amello Jason | CorpContrllr,ChiefA ... | Option Exercise | A | 58.66 | 5,455 | 319,990 | 5,455 | |
May 26 2009 | GENZ | GENZYME CORP | Amello Jason | CorpContrllr,ChiefA ... | Option Exercise | A | 0.00 | 1,818 | 0 | 1,818 | |
May 26 2009 | GENZ | GENZYME CORP | SYRON RICHARD F/CA | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 26 2009 | GENZ | GENZYME CORP | SYRON RICHARD F/CA | Director | Option Exercise | A | 58.66 | 7,500 | 439,950 | 7,500 | |
May 26 2009 | GENZ | GENZYME CORP | SYRON RICHARD F/CA | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 26 2009 | GENZ | GENZYME CORP | SYRON RICHARD F/CA | Director | Buy | M | 0.00 | 2,500 | 0 | 2,511 | 11 to 2.5 K (+22,727.27 %) |
May 26 2009 | GENZ | GENZYME CORP | WYZGA MICHAEL S | Executive VP and CF ... | Option Exercise | A | 58.66 | 42,750 | 2,507,715 | 42,750 | |
May 26 2009 | GENZ | GENZYME CORP | WYZGA MICHAEL S | Executive VP and CF ... | Option Exercise | A | 0.00 | 14,250 | 0 | 14,250 | |
May 26 2009 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | A | 58.66 | 42,750 | 2,507,715 | 42,750 | |
May 26 2009 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | A | 0.00 | 14,250 | 0 | 14,250 | |
May 26 2009 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | A | 58.66 | 23,038 | 1,351,409 | 23,038 | |
May 26 2009 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | A | 0.00 | 7,679 | 0 | 7,679 | |
May 26 2009 | GENZ | GENZYME CORP | MCGILLICUDY CORNELIUS III | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 26 2009 | GENZ | GENZYME CORP | MCGILLICUDY CORNELIUS III | Director | Option Exercise | A | 58.66 | 7,500 | 439,950 | 7,500 | |
May 26 2009 | GENZ | GENZYME CORP | MCGILLICUDY CORNELIUS III | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 26 2009 | GENZ | GENZYME CORP | MCGILLICUDY CORNELIUS III | Director | Buy | M | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
May 26 2009 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 26 2009 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 58.66 | 7,500 | 439,950 | 7,500 | |
May 26 2009 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 26 2009 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Buy | M | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
May 26 2009 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | A | 58.66 | 16,625 | 975,223 | 16,625 | |
May 26 2009 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | A | 0.00 | 5,542 | 0 | 5,542 | |
May 26 2009 | GENZ | GENZYME CORP | COLLIER EARL M JR | Executive Vice Pres ... | Option Exercise | A | 58.66 | 42,750 | 2,507,715 | 42,750 | |
May 26 2009 | GENZ | GENZYME CORP | COLLIER EARL M JR | Executive Vice Pres ... | Option Exercise | A | 0.00 | 14,250 | 0 | 14,250 | |
May 26 2009 | GENZ | GENZYME CORP | BOUDREAUX GAIL | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
May 26 2009 | GENZ | GENZYME CORP | BOUDREAUX GAIL | Director | Option Exercise | A | 58.66 | 7,500 | 439,950 | 7,500 | |
May 26 2009 | GENZ | GENZYME CORP | BOUDREAUX GAIL | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 26 2009 | GENZ | GENZYME CORP | BOUDREAUX GAIL | Director | Buy | M | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
May 26 2009 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | A | 58.66 | 190,000 | 11,145,400 | 190,000 | |
May 26 2009 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | A | 0.00 | 63,650 | 0 | 63,650 | |
May 26 2009 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Option Exercise | A | 58.66 | 14,250 | 835,905 | 14,250 | |
May 26 2009 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Option Exercise | A | 0.00 | 4,750 | 0 | 4,750 | |
May 18 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | M | 20.59 | 1,452 | 29,897 | 0 | |
May 18 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | M | 20.59 | 10,000 | 205,900 | 1,452 | |
May 18 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Sell | S | 59.40 | 1,452 | 86,244 | 28,025 | 29.5 K to 28 K (-4.93 %) |
May 18 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Buy | M | 20.59 | 1,452 | 29,897 | 29,477 | 28 K to 29.5 K (+5.18 %) |
May 18 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Sell | S | 60.33 | 10,000 | 603,277 | 28,025 | 38 K to 28 K (-26.30 %) |
May 18 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Buy | M | 20.59 | 10,000 | 205,900 | 38,025 | 28 K to 38 K (+35.68 %) |
May 14 2009 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Sell | S | 60.19 | 3,000 | 180,570 | 8,164 | 11.2 K to 8.2 K (-26.87 %) |
May 14 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | M | 20.59 | 10,000 | 205,900 | 11,452 | |
May 14 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Sell | S | 60.62 | 10,000 | 606,238 | 28,025 | 38 K to 28 K (-26.30 %) |
May 14 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Buy | M | 20.59 | 10,000 | 205,900 | 38,025 | 28 K to 38 K (+35.68 %) |
May 13 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | M | 11.47 | 7,452 | 85,474 | 0 | |
May 13 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | M | 20.59 | 2,548 | 52,463 | 21,452 | |
May 13 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | M | 11.47 | 10,000 | 114,700 | 7,452 | |
May 13 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Sell | S | 60.70 | 7,452 | 452,304 | 28,025 | 35.5 K to 28 K (-21.01 %) |
May 13 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Sell | S | 60.70 | 2,548 | 154,653 | 35,477 | 38 K to 35.5 K (-6.70 %) |
May 13 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Buy | M | 0.00 | 2,548 | 0 | 38,025 | 35.5 K to 38 K (+7.18 %) |
May 13 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Buy | M | 0.00 | 7,452 | 0 | 35,477 | 28 K to 35.5 K (+26.59 %) |
May 13 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Sell | S | 61.28 | 10,000 | 612,775 | 28,025 | 38 K to 28 K (-26.30 %) |
May 13 2009 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Buy | M | 0.00 | 10,000 | 0 | 38,025 | 28 K to 38 K (+35.68 %) |
Apr 29 2009 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Buy | I | 52.10 | 3,772 | 196,514 | 3,772 | 0 to 3.8 K |
Apr 28 2009 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Sell | S | 53.35 | 4,000 | 213,386 | 11,164 | 15.2 K to 11.2 K (-26.38 %) |
Apr 24 2009 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Therapeutics ... | Buy | P | 51.95 | 2,000 | 103,906 | 4,227 | 2.2 K to 4.2 K (+89.81 %) |
Apr 02 2009 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 281 | 0 | 281 | |
Apr 02 2009 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 406 | 0 | 406 | |
Mar 06 2009 | GENZ | GENZYME CORP | Bamforth Mark R | Sr.VP, Corp. Operat ... | Buy | P | 54.54 | 700 | 38,178 | 3,775 | 3.1 K to 3.8 K (+22.76 %) |
Feb 25 2009 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Sell | S | 69.69 | 6,000 | 418,140 | 15,164 | 21.2 K to 15.2 K (-28.35 %) |
Jan 20 2009 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Option Exercise | M | 29.44 | 232,180 | 6,835,379 | 0 | |
Jan 20 2009 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Sell | S | 66.50 | 232,180 | 15,439,970 | 6,068 | 238.2 K to 6.1 K (-97.45 %) |
Jan 20 2009 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Buy | M | 29.44 | 232,180 | 6,835,379 | 238,248 | 6.1 K to 238.2 K (+3,826.30 %) |
Jan 05 2009 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 302 | 0 | 302 | |
Jan 05 2009 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 420 | 0 | 420 | |
Dec 12 2008 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Buy | P | 64.80 | 1,550 | 100,440 | 1,550 | 0 to 1.6 K |
Dec 10 2008 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | M | 29.44 | 55,521 | 1,634,538 | 0 | |
Dec 10 2008 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | S | 65.17 | 55,521 | 3,618,304 | 30,495 | 86 K to 30.5 K (-64.55 %) |
Dec 10 2008 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Buy | M | 29.44 | 55,521 | 1,634,538 | 86,016 | 30.5 K to 86 K (+182.07 %) |
Nov 05 2008 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Sell | S | 74.59 | 11,200 | 835,408 | 66,158 | 77.4 K to 66.2 K (-14.48 %) |
Oct 02 2008 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 198 | 0 | 198 | |
Oct 02 2008 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 262 | 0 | 262 | |
Aug 18 2008 | GENZ | GENZYME CORP | Meeker David P | President LSD Thera ... | Option Exercise | M | 20.59 | 1,802 | 37,103 | 0 | |
Aug 18 2008 | GENZ | GENZYME CORP | Meeker David P | President LSD Thera ... | Option Exercise | M | 20.59 | 15,988 | 329,193 | 0 | |
Aug 18 2008 | GENZ | GENZYME CORP | Meeker David P | President LSD Thera ... | Sell | S | 83.19 | 17,790 | 1,479,950 | 1,886 | 19.7 K to 1.9 K (-90.41 %) |
Aug 18 2008 | GENZ | GENZYME CORP | Meeker David P | President LSD Thera ... | Buy | M | 20.59 | 1,802 | 37,103 | 19,676 | 17.9 K to 19.7 K (+10.08 %) |
Aug 18 2008 | GENZ | GENZYME CORP | Meeker David P | President LSD Thera ... | Buy | M | 20.59 | 15,988 | 329,193 | 17,874 | 1.9 K to 17.9 K (+847.72 %) |
Sep 25 2008 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | M | 26.50 | 13,434 | 356,001 | 18,318 | |
Sep 25 2008 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | M | 29.44 | 23,201 | 683,037 | 0 | |
Sep 25 2008 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Sell | S | 76.73 | 36,635 | 2,811,004 | 15,478 | 52.1 K to 15.5 K (-70.30 %) |
Sep 25 2008 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Buy | M | 26.50 | 13,434 | 356,001 | 52,113 | 38.7 K to 52.1 K (+34.73 %) |
Sep 25 2008 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Buy | M | 29.44 | 23,201 | 683,037 | 38,679 | 15.5 K to 38.7 K (+149.90 %) |
Aug 15 2008 | GENZ | GENZYME CORP | SMITH ALAN E | Senior Vice Preside ... | Option Exercise | M | 32.52 | 15,000 | 487,800 | 66,300 | |
Aug 15 2008 | GENZ | GENZYME CORP | SMITH ALAN E | Senior Vice Preside ... | Sell | S | 82.51 | 15,000 | 1,237,650 | 30,495 | 45.5 K to 30.5 K (-32.97 %) |
Aug 15 2008 | GENZ | GENZYME CORP | SMITH ALAN E | Senior Vice Preside ... | Buy | M | 32.52 | 15,000 | 487,800 | 45,495 | 30.5 K to 45.5 K (+49.19 %) |
Aug 08 2008 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP General Couns ... | Option Exercise | M | 32.52 | 10,725 | 348,777 | 0 | |
Aug 08 2008 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP General Couns ... | Sell | S | 78.99 | 10,725 | 847,168 | 716 | 11.4 K to 716 (-93.74 %) |